Sandra Kanan

Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia

Steven P. Treon, Christina Tripsas, Kirsten Meid et al. · New England Journal of Medicine · 2015 · 913 citations · Full text

The WHIM-like CXCR4S338X somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom’s Macroglobulinemia

Yang Cao, Zachary R. Hunter, Xingguang Liu et al. · Leukemia · 2014 · 231 citations

Somatic Variant, Novel Therapy, Medicine +7

Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemia

Steven P. Treon, Christina Tripsas, Kirsten Meid et al. · Blood · 2014 · 177 citations · Full text

Clonal architecture of <i><scp>CXCR</scp>4 </i><scp>WHIM</scp>‐like mutations in Waldenström Macroglobulinaemia

Lian Xu, Zachary R. Hunter, Nicholas Tsakmaklis et al. · British Journal of Haematology · 2015 · 135 citations

Hematological Malignancy, Waldenström Macroglobulinaemia, Lymphoid Neoplasia +15

Overall survival and competing risks of death in patients with <scp>W</scp>aldenström macroglobulinaemia: an analysis of the<scp>S</scp>urveillance,<scp>E</scp>pidemiology and<scp>E</scp>nd<scp>R</scp>esults database

Jorge J. Castillo, Adam J. Olszewski, Sandra Kanan et al. · British Journal of Haematology · 2014 · 129 citations

Disease Progression, Prognosis, Epidemiology Of Cancer +22